Public lists: Medical Devices (6162)

NICO is dedicated to developing technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to positively impact patient's lives, families, the care giver, and the health system provider.

NICO is dedicated to developing technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to positively impact patient's lives, families, the...Show all

Company (Alive / Active)

Phone: 317-660-7118

Fax:

250 E. 96th Street
Suite 125
Indianapolis, 46240
Indiana, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NICO $53.9M Oct 31, 2018
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NICO Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors

Vertiflex

Carlsbad, California, United States
Alive / ActiveVertiflex is a developer of minimally invasive interventions for spinal stenosis. Vertiflex is advancing Superion Indirect Decompression System, a minimally invasive spinal implant designed to treat moderate lumbar spinal stenosis. Once implanted, Superion is intended to reduce pressure on the affected nerves and allow patients to return to a more active lifestyle.Login to see details

SurgRx

Redwood City, California, United States
AcquiredSurgRx, Inc. has developed proprietary technology for tissue sealing and cutting, to be used in surgical procedures. The company's products have applications in the gynecology, transplantation, and general surgery markets, whether used endoscopically or in open procedures. The total market potential for these products is in excess of $4 billion. The SurgRx tissue sealing device is deemed safe by the FDA and has been granted 510K regulatory approval.Login to see details
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
System and method of taking and collecting tissue cores for treatment Oct 14, 2014 Apr 03, 2018 Patent
Motor driven surgical instrument with fluid control circuit May 31, 2012 Feb 06, 2018 Patent
System for collecting and preserving tissue cores Mar 15, 2013 Nov 21, 2017 Patent
Single lumen cautery forceps Nov 10, 2014 Oct 24, 2017 Patent
Variable aspiration control device Sep 08, 2016 Oct 17, 2017 Patent
See all 59 patents